Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn’s disease

• Published in: Nature communications Vol. 10; no. 1; pp. 5629 - 11
• Main Authors: Ziegler, Jörn F., Böttcher, Chotima, Letizia, Marilena, Yerinde, Cansu, Wu, Hao, Freise, Inka, Rodriguez-Sillke, Yasmina, Stoyanova, Ani K., Kreis, Martin E., Asbach, Patrick, Kunkel, Desiree, Priller, Josef, Anagnostopoulos, Ioannis, Kühl, Anja A., Miehle, Konstanze, Stumvoll, Michael, Tran, Florian, Fredrich, Broder, Forster, Michael, Franke, Andre, Bojarski, Christian, Glauben, Rainer, Löscher, Britt-Sabina, Siegmund, Britta, Weidinger, Carl
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 10.12.2019; Nature Publishing Group; Nature Portfolio
• Subjects: 13/31; 14/63; 38/23; 59/57; 692/163/2743/348; 692/4020/1503/257/1402; 82/51; 96/106; 96/21; 96/95; Cell Line; Colon; Crohn Disease - complications; Crohn Disease - pathology; Humanities and Social Sciences; Humans; Inflammation; Inflammation - drug therapy; Inflammatory bowel diseases; Intestine; Killer Cells, Natural; Leptin; Leptin - therapeutic use; Leukocytes; Lipodystrophy; Lipodystrophy, Congenital Generalized - complications; Male; multidisciplinary; Phenotype; Science; Science (multidisciplinary); T-Lymphocytes - cytology; Tumor Necrosis Factor-alpha - metabolism; Tumor necrosis factor-α; Wound Healing - drug effects
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-019-13559-7

Leptin has been shown to modulate intestinal inflammation in mice. However, clinical evidence regarding its immune-stimulatory potential in human Crohn’s disease remains sparse. We here describe a patient with the unique combination of acquired generalized lipodystrophy and Crohn’s disease (AGLCD) featuring a lack of adipose tissue, leptin deficiency and intestinal inflammation. Using mass and flow cytometry, immunohistochemistry and functional metabolic analyses, the AGLCD patient was compared to healthy individuals and Crohn’s disease patients regarding immune cell composition, function and metabolism and the effects of recombinant N -methionylleptin (rLeptin) were evaluated. We provide evidence that rLeptin exerts diverse pro-inflammatory effects on immune cell differentiation and function, including the metabolic reprogramming of immune cells and the induction of TNFα, ultimately aggravating Crohn’s disease in the AGLCD patient, which can be reversed by anti-TNFα therapy. Our results indicate that leptin is required for human immune homeostasis and contributes to autoimmunity in a TNFα-dependent manner. The adipokine leptin modulates intestinal inflammation in mice. Here the authors describe a patient with inflammatory bowel disease and lipodystrophy, providing evidence that leptin aggravates intestinal inflammation with proinflammatory effects on leukocytes that are reversible by TNFα blockade.